We are live on ! Find out more
HLVX

HilleVax
HLVX

Delisted

HLVX was delisted on the 16th of September, 2025.

Back to rankings

1 hedge funds and large institutions have $0 invested in HilleVax in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

82.38% less ownership

Funds ownership: 82.73% → 0.36% (-82%)

99% less funds holding

Funds holding: 74 → 1 (-73)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $82.5M → $0 (-$82.5M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 73

Holders
1
Holders Change
-73
Holders Change %
-98.65%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
73
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$285K

Top Sellers

Rank Fund Capital Flow
1
FLSM
Frazier Life Sciences Management
California
-$21.1M
2
TPC
Takeda Pharmaceutical Company
Japan
-$13.4M
3
TCM
Tang Capital Management
California
-$9.79M
4
EC
EcoR1 Capital
California
-$4.82M
5
LMC
Lightspeed Management Company
California
-$4.58M

HLVX Hedge Fund Activity: Q3 2025 in Review

1 of the 7,643 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q3 2025, worth a combined $0 — down 100% from $82.5M a quarter earlier.

Sellers outnumbered buyers: 73 funds closed out of HLVX and 0 opened new positions — a net loss of 73 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was XTX Topco, adding an estimated $285K. The largest seller was Frazier Life Sciences Management, exiting entirely with an estimated $21.1M sold.

  • 1 institutional investor held HilleVax (HLVX) as of Q3 2025, down from 74 in Q2 2025.
  • Funds reported $0 of HilleVax stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new HilleVax positions in Q3 2025 and 73 closed out, a net change of -73 holders.
  • The largest HilleVax buyer in Q3 2025 was XTX Topco, an estimated $285K added.
  • The largest HilleVax seller in Q3 2025 was Frazier Life Sciences Management, an estimated $21.1M sold.

Based on aggregated 13F filings for Q3 2025.